PHR8918
Fluticasone EP Impurity I
certified reference material, pharmaceutical secondary standard
别名:
6α,9-difluoro-17β-[(fluoromethoxy)carbonothioyl]-11β-hydroxy-16α-methyl-3-oxoandrosta-1,4-dien-17α-yl furan-2-carboxylate, Androsta-1,4-dien-3-one, 17,17′-(trithiodicarbonyl)bis[6,9-difluoro-11-hydroxy-16-methyl-17-(1-oxopropoxy)-, (6α,11β,16α,17α)-(6′α,11′β,16′α,17′α), Fluticasone EP Impurity I
grade
certified reference material, pharmaceutical secondary standard
agency
(Not traceable to any primary pharmacopeia standard)
API family
fluticasone
CofA
current certificate can be downloaded
packaging
pkg of 100 mg
application(s)
pharmaceutical
storage temp.
-10 to -25°C
Quality Level
General description
Pharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards
Analysis Note
These secondary standards offer multi-traceability to the USP and EP primary standards, where they are available.
Other Notes
This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis.
signalword
Warning
hcodes
Hazard Classifications
Repr. 2 - STOT RE 2
target_organs
Endocrine system
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
法规信息
新产品
此项目有
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持